Domestic brokerage firm JM Financial recently initiated coverage on Brainbees Solutions, operating under the FirstCry brand, with a 'buy' rating and a target price of ₹692 per share, citing the company's strong growth opportunities in the childcare platform. The company has defined clear drivers for gross margin expansion since FY24, which include the rising mix of FirstCry home brands, COCO …
Gland Pharma remains on track to deliver growth, but at the same time, it continues to be vigilant about not being over dependent on a specific geography, said brokerage Nirmal Bang in a note as it hosted the Gland Pharma management at its Annual Investor Conference to discuss the company’s business outlook. The brokerage house has a Buy rating on …